All News

    Rina-S Earns Breakthrough Designation in Advanced Endometrial Cancer

    August 26th 2025, 4:00pm

    Article

    Rina-S earned breakthrough therapy designation for patients with advanced endometrial cancer whose disease has worsened after platinum-based chemotherapy.

    FDA Grants Breakthrough Device Status to MRD Test in Colorectal Cancer

    August 26th 2025, 3:00pm

    Article

    The FDA granted breakthrough device designation to Quest Diagnostics’ Haystack MRD test for patients with stage 2 colorectal cancer after surgery.

    Why Patients With Cancer ‘Have to Be Our Own Advocates’

    August 26th 2025, 1:00pm

    Video

    Kristen Dahlgren of the Cancer Vaccine Coalition spoke with CURE about patients’ need to find reliable sources of information.

    Standing Up to Cancer and How I Do it

    August 25th 2025, 9:00pm

    Article

    What does standing up to cancer mean to me? It meant I got to choose the terms of my fight instead of relinquishing that to an uncurable disease.

    Rusfertide Earns Breakthrough Therapy Designation in Polycythemia Vera

    August 25th 2025, 8:00pm

    Article

    The FDA has granted rusfertide breakthrough therapy designation for patients with polycythemia vera, a step that could speed its path to approval.

    Biopsy Alone May Miss Risk in Grade Group 1 Prostate Cancer

    August 25th 2025, 7:00pm

    Article

    Dr. Neal Patel says biopsy results may not fully capture prostate cancer risk, stressing that PSA, stage and disease volume should also guide treatment.

    HMAs Underutilized in Older, Female and Non-White Patients with MDS

    August 25th 2025, 5:00pm

    Article

    In patients with high-risk myelodysplastic syndromes, hypomethylating agents are underutilized, particularly among older, female and non-White patients.

    Find Your Own Metaphors: Advice For Cancer Survivors

    August 25th 2025, 4:00pm

    Article

    Creating our own metaphors to stand up to cancer can help with the healing journey; own words can give us a better sense of control.

    DecisionDx-SCC Test Helps Predict Outcomes in High-Risk Skin Cancer

    August 25th 2025, 3:00pm

    Article

    DecisionDx-SCC may help doctors more accurately guide treatment in high-risk cutaneous squamous cell carcinoma, the second most common form of skin cancer.

    Hope and Support Guides Survivor Through Ovarian Cancer Journey

    August 25th 2025, 1:00pm

    Article

    A survivor shares how family, care teams and mentoring others helped her face stage 3C ovarian cancer and reclaim independence with hope.